tranexamic acid Ampoules, injection 1000 mg / 10 mL

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17924
The company was founded in the 1930s. They manufacture medicines and biomedical materials of the highest quality with scientifically proven efficacy and safety, designed to help save the lives of patients. They even are a manufacturer of parenteral solutions, blood transfusion bags, special small-volume injectables, and disposable medical products for critical care of critically ill patients, and their market directly to health institutions.

Manufacturer usually replies in 12 days

Tranexamic acid is a coagulation modifier class medication that is used to prevent blood loss after major trauma, factor IX deficiency, hemophilia type A, melasma, nosebleeds, menorrhagia, and menstrual disorders. Manufacturing companies produce it as both standalone medication and in combination drug formulations, along with ingredients such as etamsylate and mefenamic acid. Suppliers market it in the forms of 100mg/ml solution for intravenous injection and 500mg tablets. In use for over 50 years, tranexamic acid is an inexpensive and widely used treatment. The World Health Organisation has included it in its list of Essential Medicines that contains the safest and most effective drugs recommended for a health system. Major pharmaceutical manufacturers and supplies of tranexamic acid include Pfizer and Sanofi-Aventis. Tranexamic acid is available in both trade name and generic formulations. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.